Patent Picks—Esters for Feel, UV Protection, Salt-free Thickening and More

By: Rachel Grabenhofer, C&T magazine

Posted: August 24, 2010

page 3 of 4

The disclosed invention relates to use of a milk apoprotein or a mixture thereof to prevent or treat microbial or viral infection of the human or animal body. It is believed that this is achieved by inhibiting the adhesion of potential pathogens. Preferably, at least one milk apoprotein is administered, simultaneously or sequentially, with at least one free fatty acid or a monoglyceride thereof; and/or at least one organic acid or a salt or ester thereof or a mixture thereof. The active agent(s) may be delivered through a pharmaceutically acceptable delivery system including solutions, ointments, eye drops, nasal sprays, intravaginal devices, surgical dressings, medical foods or drinks, oral health care formulations and medicaments for mucosal applications. The delivery system may comprise oral hygiene products such as chewing gums, mouthwash, toothpaste and denture adhesives.

Compositions containing chalcones and uses thereof 
US Patent 7781410
Publication date: Aug. 24, 2010
Assignee: Johnson & Johnson

The described invention features a composition comprising a chalcone and describes the use thereof for treating acne and reducing the appearance of oil or pores on the skin, hair and scalp.

Shampoo compositions containing a combination of cationic polymers
US Patent 7781386
Publication date: August 24, 2010
Assignee: Conopco Inc.

The present invention provides an aqueous shampoo composition comprising: one or more anionic cleansing surfactants; preferably discrete, dispersed droplets of a water-insoluble conditioning agent with a mean droplet diameter of 4 micrometers or less; one or more cationic polymers selected from cationically modified acrylamide polymers having a cationic charge density at pH 7 of less than 1.0 meq/g, and cationically modified celluloses and mixtures thereof; and one or more cationic polymers selected from cationically modified acrylamide polymers having a cationic charge density at pH 7 of greater than 1.0 meq/g, cationically modified polygalactomannans, and mixtures thereof, wherein the composition comprises a cationic polymer other than a cationically modified acrylamide polymer.